apricus wealth, LLC - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 118 filers reported holding RELMADA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.

Quarter-by-quarter ownership
apricus wealth, LLC ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$239,822
+9.2%
77,362
+0.0%
0.21%
+8.8%
Q2 2023$219,614
+25.7%
77,3290.0%0.19%
+21.4%
Q1 2023$174,764
-35.2%
77,3290.0%0.16%
-35.4%
Q4 2022$269,878
-93.2%
77,329
-28.0%
0.25%
-93.8%
Q3 2022$3,973,000
+527.6%
107,329
+222.0%
3.94%
+581.3%
Q2 2022$633,000
-28.5%
33,334
-1.8%
0.58%
-19.8%
Q1 2022$885,000
+15.7%
33,9340.0%0.72%
+5.7%
Q4 2021$765,00033,9340.68%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Guild Investment Management, Inc. 205,300$615,9001.03%
Deep Track Capital, LP 2,837,818$8,513,4540.33%
PARSONS CAPITAL MANAGEMENT INC/RI 974,082$2,922,2460.23%
apricus wealth, LLC 77,362$239,8220.21%
Palo Alto Investors LP 732,400$2,197,2000.21%
RTW INVESTMENTS, LP 2,131,835$6,395,5050.14%
SILVERARC CAPITAL MANAGEMENT, LLC 100,000$300,0000.09%
AdvisorShares Investments LLC 112,908$338,7240.09%
Savior LLC 3,500$10,5000.07%
Spotlight Asset Group, Inc. 20,000$60,0000.05%
View complete list of RELMADA THERAPEUTICS INC shareholders